Literature DB >> 26122118

Effect of medical expulsive therapy on the health-related quality of life of patients with ureteral stones: a critical evaluation.

Bilal Eryildirim1, Cahit Sahin, Murat Tuncer, Kubilay Sabuncu, Cihangir Cetinel, Fatih Tarhan, Kemal Sarica.   

Abstract

PURPOSE: To evaluate the possible effects of medical expulsive therapy (MET) on the health-related quality of life (HRQOL) of the patients under watchful waiting for ureteral stones. PATIENTS AND METHODS: A total 120 patients with ureteral stones were included into this study program. Patients were divided into two subgroups. While patients in group 1 received medical therapy only for colic pain if needed, patients in group 2 received MET (tamsulosin 0.4 mg/once daily) in addition to medical therapy. All cases were evaluated weekly during 1-month period, and the patients with persistent stones after this period in both groups were evaluated with respect to the analgesic requirement, number of renal colic attacks as well as emergency department (ED) visits along with the QOL scores.
RESULTS: Mean values of patient age and stone burden were 37.14 ± 2.46 years and 42.04 ± 2.03 mm(2), respectively. Evaluation of the cases with residing stones after 4 weeks (28 cases in group 1 and 27 cases in group 2) with or without MET revealed following findings; renal colic, total amount of analgesic required and the mean number of ED visits were significantly lower in cases receiving MET. Evaluation of the mean HRQOL in terms of EQ-5D index and EQ-5D VAS values in both groups again demonstrated higher mean values in patients undergoing MET (p < 0.05).
CONCLUSION: Our findings indicated that MET for ureteral calculi during watchful waiting period could increase the HRQOL scores by lowering the number of both renal colic attacks and ED visits resulting in decreased analgesic need.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26122118     DOI: 10.1007/s11255-015-1036-7

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  18 in total

1.  Relationship of spontaneous passage of ureteral calculi to stone size and location as revealed by unenhanced helical CT.

Authors:  Deirdre M Coll; Michael J Varanelli; Robert C Smith
Journal:  AJR Am J Roentgenol       Date:  2002-01       Impact factor: 3.959

Review 2.  Management of ureteral calculi: a cost comparison and decision making analysis.

Authors:  Yair Lotan; Matthew T Gettman; Claus G Roehrborn; Jeffrey A Cadeddu; Margaret S Pearle
Journal:  J Urol       Date:  2002-04       Impact factor: 7.450

Review 3.  Medical therapy to facilitate the passage of stones: what is the evidence?

Authors:  Christian Seitz; Evangelos Liatsikos; Francesco Porpiglia; Hans-Göran Tiselius; Ulrike Zwergel
Journal:  Eur Urol       Date:  2009-06-21       Impact factor: 20.096

4.  Time to stone passage for observed ureteral calculi: a guide for patient education.

Authors:  O F Miller; C J Kane
Journal:  J Urol       Date:  1999-09       Impact factor: 7.450

5.  Effect of tamsulosin on the number and intensity of ureteral colic in patients with lower ureteral calculus.

Authors:  Sefa Resim; Hasan Ekerbicer; Ahmet Ciftci
Journal:  Int J Urol       Date:  2005-07       Impact factor: 3.369

Review 6.  Epidemiology and medical management of stone disease.

Authors:  H-G Tiselius
Journal:  BJU Int       Date:  2003-05       Impact factor: 5.588

7.  Prevalence of kidney stones in the United States.

Authors:  Charles D Scales; Alexandria C Smith; Janet M Hanley; Christopher S Saigal
Journal:  Eur Urol       Date:  2012-03-31       Impact factor: 20.096

8.  Understanding the barriers to the dissemination of medical expulsive therapy.

Authors:  John M Hollingsworth; J Stuart Wolf; Gary J Faerber; William W Roberts; Rodney L Dunn; Brent K Hollenbeck
Journal:  J Urol       Date:  2010-10-16       Impact factor: 7.450

9.  Alfuzosin stone expulsion therapy for distal ureteral calculi: a double-blind, placebo controlled study.

Authors:  Renato Nardi Pedro; Bryan Hinck; Kari Hendlin; Kendall Feia; Benjamin K Canales; Manoj Monga
Journal:  J Urol       Date:  2008-04-18       Impact factor: 7.450

10.  Is there a role for tamsulosin in the treatment of distal ureteral stones of 7 mm or less? Results of a randomised, double-blind, placebo-controlled trial.

Authors:  Thomas Hermanns; Peter Sauermann; Kaspar Rufibach; Thomas Frauenfelder; Tullio Sulser; Räto T Strebel
Journal:  Eur Urol       Date:  2009-04-03       Impact factor: 20.096

View more
  4 in total

1.  Sexual intercourse as a new option in the medical expulsive therapy of distal ureteral stones in males: a prospective, randomized, controlled study.

Authors:  Zeki Bayraktar; Selami Albayrak
Journal:  Int Urol Nephrol       Date:  2017-08-12       Impact factor: 2.370

Review 2.  Medical expulsive therapy for ureteral stones: where do we go from here?

Authors:  Bhaskar K Somani; Omar Aboumarzouk; Olivier Traxer; Joyce Baard; Guido Kamphuis; Jean de la Rosette
Journal:  Nat Rev Urol       Date:  2016-08-02       Impact factor: 14.432

Review 3.  Alpha-blockers as medical expulsive therapy for ureteral stones.

Authors:  Thijs Campschroer; Xiaoye Zhu; Robin Wm Vernooij; Mtw Tycho Lock
Journal:  Cochrane Database Syst Rev       Date:  2018-04-05

Review 4.  Alpha blockers for treatment of ureteric stones: systematic review and meta-analysis.

Authors:  John M Hollingsworth; Benjamin K Canales; Mary A M Rogers; Shyam Sukumar; Phyllis Yan; Gretchen M Kuntz; Philipp Dahm
Journal:  BMJ       Date:  2016-12-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.